Healthcare provider profile · identity verified

Yanet Miranda

Nurse Practitioner · TAMPA, FL · NPI 1821567546

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	414	175
Losartan Potassium	Losartan Potassium	214	84
Metformin Hcl	Metformin Hcl	203	74
Gabapentin	Gabapentin	193	83
Amlodipine Besylate	Amlodipine Besylate	186	69
Fluticasone Propionate	Fluticasone Propionate	178	120
Lisinopril	Lisinopril	176	63
Levothyroxine Sodium	Levothyroxine Sodium	167	65
Pantoprazole Sodium	Pantoprazole Sodium	154	67
Rosuvastatin Calcium	Rosuvastatin Calcium	146	61
Omeprazole	Omeprazole	134	64
Baclofen	Baclofen	117	72
Hydrochlorothiazide	Hydrochlorothiazide	114	42
Metoprolol Succinate	Metoprolol Succinate	112	44
Albuterol Sulfate Hfa	Albuterol Sulfate	107	53
Furosemide	Furosemide	106	44
Azithromycin	Azithromycin	105	80
Alprazolam	Alprazolam	102	32
Diclofenac Sodium	Diclofenac Sodium	94	64
Ozempic	Semaglutide	88	14
Methylprednisolone	Methylprednisolone	84	55
Carvedilol	Carvedilol	79	28
Montelukast Sodium	Montelukast Sodium	79	36
Tizanidine Hcl	Tizanidine Hcl	79	49
Metoprolol Tartrate	Metoprolol Tartrate	78	31
Famotidine	Famotidine	76	43
Ammonium Lactate	Ammonium Lactate	75	28
Trazodone Hcl	Trazodone Hcl	74	29
Triamcinolone Acetonide	Triamcinolone Acetonide	74	63
Glipizide	Glipizide	71	28
Oxybutynin Chloride Er	Oxybutynin Chloride	66	30
Sertraline Hcl	Sertraline Hcl	63	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	62	54
Duloxetine Hcl	Duloxetine Hcl	62	22
Escitalopram Oxalate	Escitalopram Oxalate	62	29
Tamsulosin Hcl	Tamsulosin Hcl	59	26
Alendronate Sodium	Alendronate Sodium	56	24
Tramadol Hcl	Tramadol Hcl	55	22
Clopidogrel	Clopidogrel Bisulfate	50	20
Doxycycline Monohydrate	Doxycycline Monohydrate	50	44
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	47	22
Eliquis	Apixaban	46	15
Meloxicam	Meloxicam	44	24
Metformin Hcl Er	Metformin Hcl	44	22
Vitamin D2	Ergocalciferol (Vitamin D2)	44	24
Ibuprofen	Ibuprofen	43	22
Meclizine Hcl	Meclizine Hcl	43	27
Ondansetron Odt	Ondansetron	40	17
Jardiance	Empagliflozin	39	14
Zolpidem Tartrate	Zolpidem Tartrate	37	11
Mupirocin	Mupirocin	36	23
Pravastatin Sodium	Pravastatin Sodium	36	14
Linzess	Linaclotide	35	12
Ketoconazole	Ketoconazole	34	22
Donepezil Hcl	Donepezil Hcl	32	17
Erythromycin	Erythromycin Base	30	25
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Potassium Chloride	Potassium Chloride	29	11
Methocarbamol	Methocarbamol	28	18
Buspirone Hcl	Buspirone Hcl	27	13
Cephalexin	Cephalexin	27	18
Nifedipine Er	Nifedipine	27	suppressed
Simvastatin	Simvastatin	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Nystatin	Nystatin	24	17
Glimepiride	Glimepiride	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Azelastine Hcl	Azelastine Hcl	21	11
Hydroxyzine Hcl	Hydroxyzine Hcl	21	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Amoxicillin	Amoxicillin	17	15
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nyamyc	Nystatin	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Atenolol	Atenolol	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	12
Folic Acid	Folic Acid	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Ciclopirox	Ciclopirox	14	11
Mirtazapine	Mirtazapine	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Finasteride	Finasteride	12	suppressed
Primidone	Primidone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Metronidazole	Metronidazole	11	11
Naproxen	Naproxen	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	11
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Temazepam	Temazepam	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Topiramate	Topiramate	11	suppressed
Xiidra	Lifitegrast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error